BDBM50181390 2-(1,3-benzothiazol-2-ylsulfanyl)-N-(3-{2,3-dihydrospiro[indene-1,4'-piperidine]-1'-yl}propyl)acetamide::CHEMBL201826
SMILES: O=C(CSc1nc2ccccc2s1)NCCCN1CCC2(CCc3ccccc23)CC1
InChI Key: InChIKey=UWZUEPMEMOCBRG-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nociceptin receptor (Homo sapiens (Human)) | BDBM50181390 (2-(1,3-benzothiazol-2-ylsulfanyl)-N-(3-{2,3-dihydr...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
Banyu Tsukuba Research Institute Curated by ChEMBL | Assay Description Displacement of [125I]Tyr-nociceptin from cloned human ORL1 expressed in CHO cells | J Med Chem 49: 847-9 (2006) Article DOI: 10.1021/jm0509851 BindingDB Entry DOI: 10.7270/Q2DJ5F78 | |||||||||||
More data for this Ligand-Target Pair |